Josephine M McAuliffe
Overview
Explore the profile of Josephine M McAuliffe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
662
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elliott S, Kallewaard N, Benjamin E, Wachter-Rosati L, McAuliffe J, Patel A, et al.
NPJ Vaccines
. 2017 Dec;
2:18.
PMID: 29263874
Influenza virus remains a significant public health threat despite innovative vaccines and antiviral drugs. A major limitation to current vaccinations and therapies against influenza virus is pathogenic diversity generated by...
2.
Paules C, Lakdawala S, McAuliffe J, Paskel M, Vogel L, Kallewaard N, et al.
J Infect Dis
. 2017 Jun;
216(3):356-365.
PMID: 28633457
Background: MEDI8852 is a novel monoclonal antibody (mAb) that neutralizes both group I and group II influenza A viruses (IAVs) in vitro. We evaluated whether MEDI8852 was effective for prophylaxis...
3.
Zhu Q, McLellan J, Kallewaard N, Ulbrandt N, Palaszynski S, Zhang J, et al.
Sci Transl Med
. 2017 May;
9(388).
PMID: 28469033
Prevention of respiratory syncytial virus (RSV) illness in all infants is a major public health priority. However, no vaccine is currently available to protect this vulnerable population. Palivizumab, the only...
4.
Kallewaard N, Corti D, Collins P, Neu U, McAuliffe J, Benjamin E, et al.
Cell
. 2016 Jul;
166(3):596-608.
PMID: 27453466
Influenza virus remains a threat because of its ability to evade vaccine-induced immune responses due to antigenic drift. Here, we describe the isolation, evolution, and structure of a broad-spectrum human...
5.
Benjamin E, Wang W, McAuliffe J, Palmer-Hill F, Kallewaard N, Chen Z, et al.
J Virol
. 2014 Apr;
88(12):6743-50.
PMID: 24696468
Unlabelled: Most neutralizing antibodies elicited during influenza virus infection or vaccination target immunodominant, variable epitopes on the globular head region of hemagglutinin (HA), which leads to narrow strain protection. In...
6.
Zhu Q, Patel N, McAuliffe J, Zhu W, Wachter L, McCarthy M, et al.
J Infect Dis
. 2011 Dec;
205(4):635-8.
PMID: 22184728
Specific mutations in respiratory syncytial virus (RSV) fusion protein can cause palivizumab resistance. We assessed the incidence of sequence polymorphisms and palivizumab resistance in clinical RSV isolates collected from immunoprophylaxis-naive...
7.
Fedorko D, Nelson N, McAuliffe J, Subbarao K
J Clin Microbiol
. 2006 Apr;
44(4):1596-7.
PMID: 16597906
No abstract available.
8.
Skiadopoulos M, Biacchesi S, Buchholz U, Riggs J, Surman S, Amaro-Carambot E, et al.
J Virol
. 2004 Jun;
78(13):6927-37.
PMID: 15194769
The growth properties and antigenic relatedness of the CAN98-75 (CAN75) and the CAN97-83 (CAN83) human metapneumovirus (HMPV) strains, which represent the two distinct HMPV genetic lineages and exhibit 5 and...
9.
McAuliffe J, Surman S, Newman J, Riggs J, Collins P, Murphy B, et al.
J Virol
. 2004 Jan;
78(4):2029-36.
PMID: 14747567
The Y942H and L992F temperature-sensitive (ts) and attenuating amino acid substitution mutations, previously identified in the L polymerase of the HPIV3cp45 vaccine candidate, were introduced into homologous positions of the...
10.
Newman J, Riggs J, Surman S, McAuliffe J, Mulaikal T, Collins P, et al.
J Virol
. 2004 Jan;
78(4):2017-28.
PMID: 14747566
Human parainfluenza virus type 1 (HPIV1) is a significant cause of respiratory tract disease in infants and young children for which a vaccine is needed. In the present study, we...